Onderneming TapImmune Inc. OTC Bulletin Board
Aandelen
US8760332002
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
15/05 | Marker Therapeutics, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
30/04 | MARKER THERAPEUTICS, INC. : Een koopadvies van Ladenburg Thalmann | ZM |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 17-10-18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-11-19 |
Chief Tech/Sci/R&D Officer | 51 | 23-10-18 | |
Chief Administrative Officer | - | 01-09-15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 01-01-21 |
Nadia Agopyan
LAW | General Counsel | 62 | 15-08-19 |
General Counsel | 67 | 23-10-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 17-10-18 |
Steven Elms
BRD | Director/Board Member | 60 | 06-08-19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08-12-21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 17-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 919 095 | 7 830 643 ( 87,80 %) | 0 | 87,80 % |
Bedrijfsgegevens
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |
- Beurs
- Aandelen
- Koers MRKR
- Koers
- Onderneming TapImmune Inc.